Summary
Updated Aug 31, 2026
Daniel Joseph Oconnell is Chief Executive Officer, Director of Acumen Pharmaceuticals, Inc. (ABOS). 2 SEC Form 4 filings on record, most recently on 23 January 2026. Most recent open-market trade: sold $5K of ABOS on 23 January 2026. Lifetime open-market sales: $22K.
Recent Transactions
3Every recent SEC Form 4 transaction Daniel Joseph Oconnell has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel Joseph Oconnell files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Derek M. Meisner - $105K of ABOS open-market activity in the last 12 months
- Derrell Porter - $75K of ABOS open-market activity in the last 12 months
- Nathan B. Fountain - $14K of ABOS open-market activity in the last 12 months
- Matt Zuga - $8K of ABOS open-market activity in the last 12 months
- Eric Siemers - $6K of ABOS open-market activity in the last 12 months
- Russell Barton - $5K of ABOS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Daniel Joseph Oconnell?
Daniel Joseph Oconnell is a corporate insider, tracked as Chief Executive Officer, Director of Acumen Pharmaceuticals, Inc. (ABOS). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Daniel Joseph Oconnell last file a Form 4?
The most recent primary Form 4 on record is dated 23 January 2026, one of 2 filings going back to 2026.
Has Daniel Joseph Oconnell been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($22K) across all tracked filings.
Where can I see all of Daniel Joseph Oconnell's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Daniel Joseph Oconnell and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
